OneMedNet Corporation (ONMDW) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
OneMedNet Corporation (ONMDW) trades at $0.035. OneMedNet Corporation provides clinical imaging solutions, focusing on secure data de-identification and curation. Their iRWD solution utilizes AI to advance medical research and diagnostics. Market cap: $31.1M, Sector: Technology.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for ONMDW: ONMDW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ONMDW against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on ONMDW.
How is this calculated? →OneMedNet Corporation (ONMDW) Technology Profile & Competitive Position
OneMedNet Corporation offers AI-driven clinical imaging solutions, specializing in secure data de-identification and curation for medical research. Its iRWD platform connects medical and academic institutions, facilitating advancements in diagnostics and life sciences, while operating in a competitive software application sector.
What Is the Investment Thesis for ONMDW?
OneMedNet Corporation presents a compelling, albeit high-risk, investment case centered on its iRWD platform and its potential to disrupt the clinical imaging data management space. The company's focus on AI-driven data de-identification and curation addresses a critical need in medical research. However, with a negative profit margin of -411.1% and a negative gross margin of -151.3%, the company's financial performance raises concerns. Key value drivers include the expansion of its partner network and the increasing demand for secure data solutions in healthcare. Upcoming AI analysis could serve as a catalyst. The company's small market capitalization of $31.1M makes it susceptible to volatility.
Based on FMP financials and quantitative analysis
ONMDW Key Highlights
Market capitalization of $31.1M indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -14.10 reflects current unprofitability, suggesting the company is in a growth phase requiring substantial investment.
- Profit margin of -411.1% highlights significant operational challenges and the need for improved cost management.
- Gross margin of -151.3% indicates that the cost of goods or services exceeds revenue, requiring a fundamental shift in business strategy.
- Beta of 1.09 suggests the stock's price is slightly more volatile than the market average.
Who Are ONMDW's Competitors?
ONMDW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| API Agora, Inc. | $4.32 | -1.82% | $389M | 56 |
| IDN Intellicheck, Inc. | $2.96 | -3.10% | $60.0M | 78 |
| MAPS WM Technology, Inc. | $0.41 | +1.23% | $45.7M | 67 |
| MLGO MicroAlgo Inc. | $4.27 | +2.64% | $46.7M | 51 |
| PERF Perfect Corp. | $1.86 | +0.00% | $189M | 62 |
| RSASF RESAAS Services Inc. | $0.31 | +6.90% | $26.1M | 69 |
| WFCF Where Food Comes From, Inc. | $13.05 | +4.40% | $65.8M | 71 |
| RSSS Research Solutions, Inc. | $2.20 | -0.45% | $73.6M | 75 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ONMDW's Key Strengths?
Proprietary iRWD platform with AI capabilities.
- Strong focus on data security and compliance.
- Established network of partner institutions.
- Expertise in clinical imaging data management.
What Are ONMDW's Weaknesses?
Negative profit and gross margins.
- Small market capitalization.
- Limited financial resources.
- Dependence on a single product (iRWD).
What Could Drive ONMDW Stock Higher?
AI analysis of iRWD platform could validate its effectiveness and attract new customers.
- Expansion of partner network will drive increased data volume and revenue growth.
- Increasing demand for secure data solutions in healthcare will fuel adoption of iRWD.
What Are the Key Risks for ONMDW?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition in the healthcare IT market could erode market share.
- Evolving data privacy regulations could increase compliance costs.
- Technological disruptions could render iRWD obsolete.
- Negative profit and gross margins pose a threat to financial sustainability.
- Small market capitalization makes the company vulnerable to market volatility.
What Are the Growth Opportunities for ONMDW?
- Expansion of iRWD Platform: OneMedNet can expand the functionality of its iRWD platform to include additional AI-powered tools for image analysis and diagnostics. The global AI in healthcare market is projected to reach $95 billion by 2030. By integrating advanced AI algorithms, OneMedNet can attract a wider range of customers, including pharmaceutical companies and diagnostic imaging centers, seeking to improve research outcomes and clinical decision-making. Timeline: 2027.
- Strategic Partnerships: Forming strategic partnerships with leading medical research institutions and pharmaceutical companies can accelerate the adoption of OneMedNet's solutions. These partnerships can provide access to valuable data and expertise, as well as enhance the company's credibility and market reach. The market for partnerships in healthcare is constantly evolving, with a focus on data sharing and collaborative research. Timeline: Ongoing.
- Geographic Expansion: Expanding its operations beyond the United States into international markets, particularly Europe and Asia, can significantly increase OneMedNet's customer base. The global healthcare IT market is experiencing rapid growth in these regions, driven by increasing healthcare spending and the adoption of digital technologies. Timeline: 2028.
- Data Monetization: Exploring opportunities to monetize the de-identified data curated by its iRWD platform can create new revenue streams. This could involve providing access to aggregated data sets for research purposes, while ensuring compliance with privacy regulations. The market for healthcare data analytics is projected to reach $76.7 billion by 2030. Timeline: 2027.
- Acquisition of Complementary Technologies: Acquiring companies with complementary technologies, such as AI-powered image analysis tools or data security solutions, can strengthen OneMedNet's competitive position and expand its product offerings. The market for healthcare IT acquisitions is active, with companies seeking to consolidate their market share and enhance their capabilities. Timeline: 2028.
What Are ONMDW's Competitive Advantages?
- Proprietary iRWD platform with AI-driven capabilities.
- Strong focus on data security and compliance.
- Established network of partner institutions.
- Expertise in clinical imaging data management.
What Does ONMDW Do?
OneMedNet Corporation, headquartered in Eden Prairie, Minnesota, is a technology company focused on providing clinical imaging solutions to the medical research and healthcare industries. The company's core offering is iRWD, a platform designed to securely de-identify, search, and curate imaging data. This technology enables medical and academic research institutions within its partner network to accelerate progress in various stages of medical research, discovery, and diagnostics across the life sciences. Founded with the vision of streamlining access to and utilization of clinical imaging data, OneMedNet addresses the challenges associated with data privacy and security while maximizing the value of medical images for research purposes. The company's solutions facilitate collaboration among researchers, enabling them to leverage large datasets for more effective and efficient studies. By providing a secure and compliant environment for data sharing, OneMedNet aims to drive innovation and improve patient outcomes in the healthcare sector. The company operates primarily in the United States, serving a network of medical and academic institutions.
What Products and Services Does ONMDW Offer?
- Provides clinical imaging solutions to medical research institutions.
- Offers iRWD, a platform for secure data de-identification and curation.
- Utilizes AI to enhance data search and analysis capabilities.
- Facilitates collaboration among researchers through secure data sharing.
- Supports advancements in medical research, discovery, and diagnostics.
- Helps organizations comply with data privacy regulations.
How Does ONMDW Make Money?
- Subscription-based access to the iRWD platform.
- Data curation and de-identification services.
- Potential for data monetization through research partnerships.
- Customized solutions tailored to specific client needs.
What Industry Does ONMDW Operate In?
OneMedNet Corporation operates within the competitive healthcare software market, which is experiencing rapid growth driven by the increasing adoption of AI and cloud-based solutions. The market is characterized by stringent regulatory requirements, particularly regarding data privacy and security. Competitors such as API, IDN, MAPS, MLGO, and PERF are vying for market share. OneMedNet's focus on secure data de-identification positions it to capitalize on the growing demand for compliant data solutions in medical research.
Who Are ONMDW's Key Customers?
- Medical research institutions.
- Academic research centers.
- Pharmaceutical companies.
- Diagnostic imaging centers.
Company Profile
OneMedNet Corporation operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Eden Prairie, US. The company is led by CEO Aaron Green. ONMDW has traded publicly since 2022.
Financial Health
OneMedNet Corporation's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ONMDW Financials
Bull Case vs Bear Case
Bull Case
- Proprietary iRWD platform with AI capabilities.
- Strong focus on data security and compliance.
- Established network of partner institutions.
- Expertise in clinical imaging data management.
Bear Case
- Negative profit and gross margins.
- Small market capitalization.
- Limited financial resources.
- Dependence on a single product (iRWD).
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
ONMDW Latest News
No recent news available for ONMDW.
ONMDW Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ONMDW.
Price Targets
Wall Street price target analysis for ONMDW.
ONMDW MoonshotScore
What does this score mean?
The MoonshotScore rates ONMDW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Aaron Green
CEO
Aaron Green serves as the CEO of OneMedNet Corporation, leading a team of 22 employees. His background includes experience in technology and healthcare, with a focus on developing and implementing innovative solutions for data management and analysis. He has a proven track record of driving growth and building strategic partnerships. His expertise lies in leveraging technology to improve healthcare outcomes and streamline research processes. He holds a degree in Computer Science and an MBA from a leading business school.
Track Record: Under Aaron Green's leadership, OneMedNet has focused on the development and commercialization of its iRWD platform. He has overseen the expansion of the company's partner network and the implementation of AI-driven capabilities. Key milestones include securing partnerships with major medical research institutions and achieving compliance with stringent data privacy regulations. He has also focused on improving operational efficiency and cost management.
OneMedNet Corporation Technology Stock: Key Questions Answered
What does OneMedNet Corporation do?
OneMedNet Corporation specializes in providing clinical imaging solutions, primarily through its iRWD platform. This platform utilizes AI to securely de-identify, search, and curate imaging data, enabling medical and academic research institutions to advance medical research and diagnostics. The company's focus is on facilitating secure data sharing and collaboration among researchers, while ensuring compliance with stringent data privacy regulations.
What do analysts say about ONMDW stock?
As of March 17, 2026, there is limited analyst coverage available for ONMDW stock due to its small market capitalization and OTC listing. Key valuation metrics, such as the negative P/E ratio and profit margin, reflect the company's current unprofitability. Growth considerations include the potential of the iRWD platform and the increasing demand for secure data solutions in healthcare.
What are the main risks for ONMDW?
OneMedNet Corporation faces several key risks, including intense competition in the healthcare IT market, evolving data privacy regulations, and potential technological disruptions. The company's negative profit and gross margins pose a significant threat to its financial sustainability. Additionally, its small market capitalization makes it vulnerable to market volatility and economic downturns.
What are the key factors to evaluate for ONMDW?
Evaluate ONMDW on fundamentals, analyst consensus, and risk factors. OneMedNet Corporation presents a compelling, albeit high-risk, investment case centered on its iRWD platform and its potential to disrupt the clinical imaging data management space. Not financial advice.
How frequently does ONMDW data refresh on this page?
ONMDW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ONMDW's recent stock price performance?
OneMedNet Corporation (ONMDW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary iRWD platform with AI capabilities. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ONMDW overvalued or undervalued right now?
OneMedNet Corporation (ONMDW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ONMDW before investing?
Before investing in OneMedNet Corporation (ONMDW), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- AI analysis is pending and may impact future performance.
- OTC stocks carry higher risks than exchange-listed stocks.